{"id":175291,"date":"2023-07-27T00:00:00","date_gmt":"2023-07-26T22:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/le-point-sur-le-daclizumab-zinbryta-5-ans-apres-sa-commercialisation\/"},"modified":"2026-04-09T17:10:31","modified_gmt":"2026-04-09T15:10:31","slug":"le-point-sur-le-daclizumab-zinbryta-5-ans-apres-sa-commercialisation","status":"publish","type":"post","link":"https:\/\/h.bcfi.be\/fr\/le-point-sur-le-daclizumab-zinbryta-5-ans-apres-sa-commercialisation\/","title":{"rendered":"Le point sur le daclizumab (Zinbryta\u00ae), 5 ans apr\u00e8s sa commercialisation"},"content":{"rendered":"<div class='summary'>Il y a 5 ans&#x002C; le daclizumab (Zinbryta&reg;) &eacute;tait commercialis&eacute; avec comme indication le traitement des formes r&eacute;currentes-r&eacute;mittentes de scl&eacute;rose en plaques. En 2018&#x002C; cet antagoniste du r&eacute;cepteur de l&#39;IL-2 a &eacute;t&eacute; retir&eacute; du march&eacute; par la firme apr&egrave;s que l&#39;Agence europ&eacute;enne des m&eacute;dicaments ait lanc&eacute; une <a href='https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-immediate-suspension-recall-multiple-sclerosis-medicine-zinbryta'>&eacute;valuation urgente<\/a> en raison du risque d&#39;enc&eacute;phalite et de m&eacute;ningo-enc&eacute;phalite.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Il y a 5 ans&#x002C; le daclizumab (Zinbryta&reg;) &eacute;tait commercialis&eacute;  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,14914],"tags":[20213,20224],"class_list":["post-175291","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2023-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/175291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/comments?post=175291"}],"version-history":[{"count":1,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/175291\/revisions"}],"predecessor-version":[{"id":177873,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/175291\/revisions\/177873"}],"wp:attachment":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/media?parent=175291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/categories?post=175291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/tags?post=175291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}